Prostate Cancer Awareness Highlights Risks and Advances in Latin America

Prostate cancer remains a common disease, affecting roughly one in eight men worldwide. In 2020 an estimated 1.4 million new cases were diagnosed. Early detection dramatically improves treatment success; men are advised to begin screening at age 50, or at 40 if they have a family history. Symptoms can include urinary urgency, weak stream, pain, and blood in the urine, though many cases are asymptomatic.

Diagnostic tools include the prostate‑specific antigen (PSA) test, digital rectal examination, transrectal ultrasound, multiparametric MRI and guided biopsy. Treatment has progressed, with robotic prostatectomy now offering minimally invasive surgery, reduced postoperative pain and faster recovery compared with traditional open procedures.

In Chile’s Magallanes region, 17 men died from prostate cancer last year, part of a national total of 2,474 deaths. Health officials stress that timely screening and modern diagnostic combinations can identify clinically significant tumors earlier and avoid unnecessary procedures.